Anthera Pharmaceuticals, Inc. (ANTH)
ANTH Stock Price Chart
Explore Anthera Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ANTH price movements and trends.
ANTH Company Profile
Discover essential business fundamentals and corporate details for Anthera Pharmaceuticals, Inc. (ANTH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Mar 2010
Employees
21.00
Website
https://www.anthera.comCEO
Paul F. Truex
Description
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.
ANTH Financial Timeline
Browse a chronological timeline of Anthera Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
ANTH Stock Performance
Access detailed ANTH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.